🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06510205
Recruiting Observational

The Study is an Observational Post-market Follow-up Program to Evaluate Long Term (5 Years) Safety of Mentor Breast Implants in Chinese Population

NCT06510205 · tracked via the Priya Life Science China tracker
Sponsor
Johnson & Johnson Medical (Shanghai) Ltd.
Phase
Observational
Started
2024-07-14
Last updated
2026-08-28

Condition(s) studied

Breast AugmentationMammaplasty

Investigational drug(s) / intervention(s)

Mentor Breast implants

Mentor Breast implants: Mentor breast implants are circular or waterdrop-shaped devices with shells made of successive cross-linked layers of silicone elastomer. The shell is filled with Mentor's proprietary formulation of silicone gel. Mentor breast implants are available in smooth and textured shells, both supplied in sterile form.

Study summary

The Mentor Post-Market Clinical Follow-Up Study is a multicenter observational study conducted in China. It aims to collect safety data on Mentor breast implants over a 5-year follow-up period in the Chinese population. In addition to safety data, the study will also gather information on postoperative pain and participant satisfaction levels. The objective is to explore customers' clinical experiences and use them as a reference for future product development. The study intends to enroll different number of participants for each license.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
100 Years
Healthy volunteers
No
Inclusion Criteria: 1. Women who have received Mentor breast implants per product instructions; 2. Participants must possess the ability to comprehend the study procedures, give consent for the use of their preoperative and surgical data, and agree to take part in postoperative follow-up assessments. Additionally, they should possess the necessary civil capacity, be capable of reading and writing, and willingly provide informed consent by signing the consent form. 3. Aged not less than 18 years at the time of implantation surgery (for products with registration license Guoxie Zhujin 20223130323, the participant's age should be not less than 22 years). Exclusion Criteria: * Not applicable

Primary outcome measure(s)

Trial sites (4)

FacilityCityRegionStatus
Sichuan Huamei Zixin Medical Aesthetic Hospital Chengdu China Recruiting
Yunnan Huamei Meilai Cosmetology Hospital Kunming China Recruiting
Shenzhen Yixing Medical Cosmetology Hospital Shenzhen China Recruiting
Shenzhen Junke Medical Cosmetology Clinic Shenzhen China Recruiting

More Johnson & Johnson Medical (Shanghai) Ltd. trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06510205 on ClinicalTrials.gov ↗ ← All trials in China